A 42-year-old woman with a history of rheumatoid arthritis (on methotrexate) presents to the emergency department with a 3-day history of fever, cough, and dyspnea. On examination: temperature 39.8°C, BP 92/58 mmHg, heart rate 128/min, respiratory rate 28/min, oxygen saturation 88% on room air. Lung auscultation reveals bilateral crackles. Blood cultures are pending. Lactate is 4.2 mmol/L (normal <2). Chest X-ray shows bilateral infiltrates. The patient is started on broad-spectrum antibiotics and fluid resuscitation. Despite 2 liters of normal saline, the BP remains 90/55 mmHg, urine output is 0.3 mL/kg/hr, and extremities remain warm. Which type of shock is this patient experiencing, and what is the underlying pathophysiologic mechanism?

Explanation

## Clinical Diagnosis This patient has **septic shock** — a subset of **distributive shock** caused by severe infection with systemic inflammatory response. ### Diagnostic Criteria Met **High-Yield:** SIRS + Infection + Hypotension = Septic Shock **Key Point:** Septic shock is defined as: 1. **Infection** (fever, infiltrates, immunocompromised host, pending blood cultures) 2. **SIRS criteria** (fever >38°C, HR >90, RR >20, elevated lactate) 3. **Hypotension** (SBP <90 mmHg despite fluid resuscitation) 4. **Tissue hypoperfusion** (oliguria, elevated lactate 4.2 mmol/L) ### Pathophysiology of Distributive Shock **Mnemonic: DISTRIBUTIVE SHOCK — The "Warm Shock" Mechanism** - **D**ysfunction of endothelial barrier → increased capillary permeability - **I**nflammatory mediators (TNF-α, IL-1, IL-6, bradykinin) → vasodilation - **S**epsis-induced vasodilation → loss of systemic vascular resistance (SVR) - **T**issue hypoperfusion despite adequate/high cardiac output (early) - **R**elative hypovolemia from third-spacing - **I**nadequate oxygen extraction at tissue level (mitochondrial dysfunction) - **B**acterial endotoxins (LPS) → TLR4 activation → NF-κB pathway - **U**ncontrolled nitric oxide (NO) production → vasodilation - **T**issue inflammation and capillary leak - **I**ncreased vascular permeability → fluid extravasation - **V**asodilation → maldistribution of blood flow - **E**ndothelial dysfunction → microvascular thrombosis ### Hemodynamic Profile: Distributive vs. Cardiogenic Shock | Parameter | Distributive (Septic) | Cardiogenic | Hypovolemic | |---|---|---|---| | **BP** | ↓ | ↓ | ↓ | | **HR** | ↑↑ (>120) | ↑ | ↑↑ | | **Extremities** | **Warm** | Cold | Cold | | **SVR** | **↓↓ (LOW)** | ↑ | ↑ | | **Cardiac Output** | ↑ (early) or ↓ (late) | ↓ | ↓ | | **PCWP** | ↓ | ↑ | ↓ | | **Lactate** | ↑ | ↑ | ↑ | | **Urine Output** | ↓ (oliguria) | ↓ | ↓ | | **Skin** | Flushed, warm | Pale, cold | Pale, cold | **Clinical Pearl:** The **warm extremities** in this patient are the key discriminator. Septic shock in early/hyperdynamic phase presents with warm, flushed skin due to massive vasodilation and high cardiac output, despite hypotension. This is opposite to cardiogenic or hypovolemic shock, where extremities are cold and clammy. ### Why This Is NOT Cardiogenic Shock **Warning:** Sepsis CAN cause secondary myocardial depression (sepsis-induced cardiomyopathy), but the PRIMARY mechanism of septic shock is **vasodilation and loss of SVR**, not pump failure. The warm extremities and initially high cardiac output distinguish it from primary cardiogenic shock (cold extremities, low CO). ### Pathophysiologic Cascade in Septic Shock ```mermaid flowchart TD A[Bacterial infection/LPS]:::outcome --> B[TLR4 activation]:::action B --> C[NF-κB & MAPK pathway]:::action C --> D[Cytokine storm<br/>TNF-α, IL-1, IL-6]:::action D --> E[Endothelial dysfunction]:::action E --> F[Massive NO production]:::action F --> G[Vasodilation & SVR ↓]:::action E --> H[Increased capillary permeability]:::action H --> I[Third-spacing & relative hypovolemia]:::action G --> J[Hypotension]:::urgent I --> J J --> K[Tissue hypoperfusion]:::urgent K --> L[Lactate accumulation<br/>Organ dysfunction]:::urgent ``` ### Management of Septic Shock **High-Yield:** The Surviving Sepsis Campaign Bundle (2021): 1. **Early recognition** and blood cultures 2. **Broad-spectrum antibiotics** within 1 hour 3. **Fluid resuscitation:** 30 mL/kg crystalloid in first 3 hours 4. **Vasopressors** if hypotension persists after fluids (norepinephrine first-line) 5. **Source control** (drainage, debridement) 6. **Supportive care** (oxygen, glucose control, stress ulcer prophylaxis) **Key Point:** Unlike cardiogenic shock, distributive shock REQUIRES aggressive fluid resuscitation FIRST, then vasopressors if needed. This patient needs vasopressors now because she remains hypotensive despite 2L fluid. [cite:Robbins 10e Ch 4; Harrison 21e Ch 325]